1C. Hasling MD,P. Charles1,F. T?geh?j Jensen,L. Mosekilde. A comparison of the effects of oestrogen/progestogen, high-dose oral calcium, intermittent cyclic etidronate and an ADFR regime on calcium kinetics and bone mass in postmenopausal women with spinal osteoporosis[J] 1994,Osteoporosis International(4):191～203
2H. Orimo,M. Shiraki,Y. Hayashi,T. Hoshino,T. Onaya,S. Miyazaki,H. Kurosawa,T. Nakamura,N. Ogawa. Effects of 1α-hydroxyvitamin D3 on lumbar bone mineral density and vertebral fractures in patients with postmenopausal osteoporosis[J] 1994,Calcified Tissue International(5):370～376
3M. Kleerekoper M.D.,E. L. Peterson,D. A. Nelson,E. Phillips,M. A. Schork,B. C. Tilley,A. M. Parfitt. A randomized trial of sodium fluoride as a treatment for postmenopausal osteoporosis[J] 1991,Osteoporosis International(3):155～161
2Macnamara P, Loughrey HC. Progesterone receptor A and B isoform expression in human osteoblasts. Calcif Tissue Int 1998; 63 (1): 39 - 46
3Yamamoto Y, Kurabayashi T, Tojo Y, et al. Effects of progestins on the metabolism of cancellous bone in aged oophorectomized rats. Bone 1998; 22 (5): 533 - 7
4Prior JC. Progesterone as a bone-trophic hormone. Endocr Rev 1990; 11(2):386 -98
5Gallagher JC, Kable WT, Goldgar D. Effect of progestin therapy on cortical and trabecular bone: comparison with estrogen. Am J Med 1991; 90 (2): 171 - 8
6Luo XH, Liao EY, Su X. Progesterone upregulates TGF-b isoforms(b1, b2, and b3) expression in normal human osteoblast-like cells. Calcif Tissue Int 2002; 71(4): 329- 34
7Le Mellay V, Lieberher M. Membrane signaling and progesterone in female and male osteoblasts. Ⅱ Direct involvement of G alpha q/11 coupled to PLC-beta 1 and PLC-beta 3. J Cell Biochem 2000; 79(2): 173 -81
8Schmidt M, Renner C, Loffer G. Progesterone inhibits glucocorticoid-dependent aromatase induction in human adipose fibroblasts. J Endocrinol 1998; 158(3):401 -7
9Palcy S, Bolivar I, Goltzman D. Role of activator protein 1 transcriptional activity in the regulation of gene expression by transforming growth factor betal and bone morphogenetic protein 2 in ROS 17/2.8 osteoblast-like cells. J Bone Miner Res 2000; 15(1
